Filtros de búsqueda

Lista de obras de

A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2014

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

artículo científico publicado en 2008

Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study

artículo científico publicado en 2016

Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial

article

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

artículo científico

Anticoagulation in heart failure: current status and future direction

artículo científico publicado en 2013

Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) tri

artículo científico

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial

artículo científico publicado en 2009

Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial

artículo científico publicado en 2013

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

artículo científico publicado en 2005

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

scientific article published on March 2010

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial

artículo científico publicado en 2014

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e

artículo científico publicado en 2009

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

article

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

artículo científico

Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study

artículo científico publicado en 2010

Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study

artículo científico publicado en 2011

Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

article

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

article

Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function

artículo científico publicado en 2010

High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.

artículo científico publicado en 2014

History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction

artículo científico

Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study

artículo científico

Improving care for patients with acute heart failure: before, during and after hospitalization

artículo científico publicado en 2014

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

artículo científico publicado en 2004

International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

artículo científico publicado en 2014

Irbesartan in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2008

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

artículo científico publicado en 2017

Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.

artículo científico publicado en 2013

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

artículo científico publicado en 2010

National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities

artículo científico publicado en 2010

Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality

artículo científico

Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

article

Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes

artículo científico publicado en 2009

Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.

artículo científico publicado en 2012

Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospital

artículo científico publicado en 2013

Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference

artículo científico publicado en 2010

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

artículo científico

QUALITY OF LIFE 60 DAYS AFTER AN ACUTE HEART FAILURE EVENT: INSIGHTS FROM THE PROTECT TRIAL

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

artículo científico publicado en 2008

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial

artículo científico publicado en 2009

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

artículo científico publicado en 2008

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

artículo científico

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

artículo científico publicado en 2004

Renal function trajectories and clinical outcomes in acute heart failure

artículo científico publicado en 2013

Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation

artículo científico publicado en 2009

Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”

Risk stratification after hospitalization for decompensated heart failure

artículo científico publicado en 2004

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

artículo científico publicado en 2010

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

artículo científico publicado en 2012

Sex-specific acute heart failure phenotypes and outcomes from PROTECT.

artículo científico publicado en 2013

Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).

artículo científico publicado en 2008

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.

artículo científico publicado en 2015

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

artículo científico publicado en 2015

The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction

artículo científico publicado en 2012

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

artículo científico publicado en 2008

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics

artículo científico publicado en 2004

The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study

artículo científico publicado en 2010

The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design

artículo científico publicado en 2005

The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure

artículo científico publicado en 2013

The prognostic importance of different definitions of worsening renal function in congestive heart failure

artículo científico publicado en 2002

The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial

artículo científico

The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.

artículo científico publicado en 2012

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

artículo científico publicado en 2012

Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure

article

Warfarin and aspirin in patients with heart failure and sinus rhythm

artículo científico publicado en 2012

Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies

artículo científico publicado en 2015

Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda